Andrew J. Mills, Director at Medline Inc. (MDLN), bought 2,586,206 shares at $29.00 ($75.0M) on 2025-12-18, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.